Cargando…

Learning Needs of Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Our results can be used in clinical settings to facilitate patient–provider discussion. They can also be used to develop educational interventions to increase knowledge and decrease uncertainty. We identified seven key informational needs: (1) possible adverse events; (2) benefits of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez-Olivo, Maria A., Kachira, Johncy J., Buni, Maryam, Kim, Sang Taek, Lu, Huifang, Tayar, Jean H., Duhon, Gabrielle F., Ruiz, Juan I., Bingham, Clifton O., Calabrese, Cassandra, Volk, Robert J., Suarez-Almazor, Maria E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416973/ https://www.ncbi.nlm.nih.gov/pubmed/37568819 http://dx.doi.org/10.3390/cancers15154004

Ejemplares similares

Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study
por: Lopez-Olivo, Maria A., et al.
Publicado: (2023)

COVID-19 Outcomes in Patients with Cancer Receiving Immune Checkpoint Inhibitors: A Systematic Review
por: Ruiz, Juan I., et al.
Publicado: (2023)

COVID-19 vaccination in patients with cancer receiving immune checkpoint inhibitors: a systematic review and meta-analysis
por: Ruiz, Juan Ignacio, et al.
Publicado: (2023)

Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis
por: Lopez-Olivo, Maria A., et al.
Publicado: (2022)

Synchronous Diagnosis of Squamous Cell Carcinoma of the Lung and Mixed Cellularity Hodgkin Lymphoma of the Nasopharynx
por: Yohannan, Binoy, et al.
Publicado: (2022)

Quality and content evaluation of websites with information about immune checkpoint inhibitors: An environmental scan
por: Ruiz, Juan Ignacio, et al.
Publicado: (2022)

The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy
por: Bruera, Sebastian, et al.
Publicado: (2022)

Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
por: Mamlouk, Omar, et al.
Publicado: (2019)

A Randomized Controlled Trial Comparing Two Self‐Administered Educational Strategies for Patients With Knee Osteoarthritis
por: Lopez‐Olivo, Maria A., et al.
Publicado: (2021)

Editorial: Multidisciplinary management of cancer patients with immune-related adverse events from checkpoint inhibitors
por: Riveiro-Barciela, Mar, et al.
Publicado: (2023)

Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case Reports
por: Abdel-Wahab, Noha, et al.
Publicado: (2016)

Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer
por: Suarez-Almazor, Maria E., et al.
Publicado: (2022)

A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis
por: Lopez-Olivo, Maria A., et al.
Publicado: (2022)

Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis
por: Pan, Xin, et al.
Publicado: (2017)

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy
por: Kim, Sang T., et al.
Publicado: (2022)

Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies
por: des Bordes, Jude, et al.
Publicado: (2020)

Immune checkpoint inhibitors for patients with pre-existing autoimmune diseases
por: Maeda, Osamu
Publicado: (2023)

A comprehensive scoping review to identify standards for the development of health information resources on the internet
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Checkpoint inhibitor-related renal vasculitis and use of rituximab
por: Mamlouk, Omar, et al.
Publicado: (2020)

Recurrent pseudogout after therapy with immune checkpoint inhibitors: a case report with immunoprofiling of synovial fluid at each flare
por: Kim, Sang T., et al.
Publicado: (2019)

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
por: Qureshi, Sehrish, et al.
Publicado: (2023)

Multidisciplinary approach to treatment with immune checkpoint inhibitors in patients with HIV, tuberculosis, or underlying autoimmune diseases
por: Aguilar-Company, Juan, et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced inflammatory arthritis: a qualitative study identifying unmet patient needs and care gaps
por: Cappelli, Laura C., et al.
Publicado: (2020)

Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series
por: Albayda, Jemima, et al.
Publicado: (2019)

Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune disease
por: Alexander, Swetha, et al.
Publicado: (2021)

Psychosocial Determinants of Total Knee Arthroplasty Outcomes Two Years After Surgery
por: Lopez‐Olivo, Maria A., et al.
Publicado: (2020)

Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis
por: Karpes Matusevich, Aliza R, et al.
Publicado: (2021)

Patients with checkpoint inhibitor‐induced inflammatory arthritis do not become seropositive for anti‐cyclic citrullinated peptide when followed over time
por: Cappelli, Laura C., et al.
Publicado: (2021)

Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature
por: Calabrese, Cassandra, et al.
Publicado: (2019)

Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
por: Arora, Sanjeevani, et al.
Publicado: (2019)

Antibody response to pneumococcal and influenza vaccination in patients with rheumatoid arthritis receiving abatacept
por: Alten, Rieke, et al.
Publicado: (2016)

Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Immune checkpoint inhibitors in patients with pre-existing psoriasis: safety and efficacy
por: Halle, Briana Rose, et al.
Publicado: (2021)

Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
por: Safa, Houssein, et al.
Publicado: (2019)

Corrections to: Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature
por: Abdel-Wahab, Noha, et al.
Publicado: (2019)

Corticosteroid-Refractory Myositis After Dual BRAF and MEK Inhibition in a Patient with BRAF V600E-Mutant Metastatic Intrahepatic Cholangiocarcinoma
por: DiPeri, Timothy P., et al.
Publicado: (2022)

Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy
por: Lusa, Amanda, et al.
Publicado: (2022)

Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors
por: Torrente, María, et al.
Publicado: (2022)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
por: Puzanov, I., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k7kbaec1du69agr0f0asbmb30p